Search Results

Willingness to receive COVID-19 vaccines, associated factors and reasons for not taking a vaccine: a cross sectional study among persons aged 13–80 years in Wakiso, Central Uganda.

• Authors : Daama, Alex^1,2 (AUTHOR) ; Rashid, Naziru^2,3,4 (AUTHOR); Asani, Kasango² (AUTHOR)

• Source: BMC Infectious Diseases. 4/11/2024, Vol. 24 Issue 1, p1-10. 10p.

Record details

Effectiveness of COVID-19 vaccines against ICU admission during Omicron surge in Saudi Arabia: a nationwide retrospective cohort study.

• Authors : Aldawish S; Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. .; Public Health Authority, Riyadh, Saudi Arabia. .

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & controlSARS-CoV-2 variants

• Source: BMC infectious diseases [BMC Infect Dis] 2023 Oct 31; Vol. 23 (1), pp. 746. Date of Electronic Publication: 2023 Oct 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis.

• Authors : Wu X; Medical School of Nanjing University, Nanjing, 210000, China.; Xu K

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Feb 21; Vol. 24 (1), pp. 234. Date of Electronic Publication: 2024 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Willingness to receive COVID-19 vaccines, associated factors and reasons for not taking a vaccine: a cross sectional study among persons aged 13–80 years in Wakiso, Central Uganda

• Authors : Alex Daama; Naziru Rashid; Kasango Asani

Subjects: Determinants; COVID-19 vaccine acceptance; Central Uganda

• Source: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)

Record details

Predictors of COVID-19 vaccine uptake: an online three-wave survey study of US adults.

• Authors : Thorpe, Alistair^1,2 (AUTHOR) ; Fagerlin, Angela^1,3 (AUTHOR); Drews, Frank A.^3,4 (AUTHOR)

• Source: BMC Infectious Diseases. 3/12/2024, Vol. 24 Issue 1, p1-9. 9p.

Record details

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis

• Authors : Xiaodi Wu; Ke Xu; Ping Zhan

Subjects: SARS-CoV-2; COVID-19; Vaccine

• Source: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024)

Record details

The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines.

• Authors : Almalki, Ohoud S.¹ (AUTHOR) ; Santali, Eman Y.² (AUTHOR); Alhothali, Abdulaziz A.³ (AUTHOR)

• Source: BMC Infectious Diseases. 6/6/2023, Vol. 23 Issue 1, p1-11. 11p.

Record details

Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.

• Authors : Hönning A; Centre for Clinical Research, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. .; Tomczyk S

Subjects: Health Personnel*/Health Personnel*/Health Personnel*/statistics & numerical data ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Apr 24; Vol. 24 (1), pp. 436. Date of Electronic Publication: 2024 Apr 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Investigating the trend of demographic changes, mortality, clinical and paraclinical findings of patients hospitalized in the Corona ward, before and after the start of general vaccination of COVID-19.

• Authors : Morovatshoar, Reza¹ (AUTHOR); Hushmandi, Kiavash² (AUTHOR); Orouei, Sara³ (AUTHOR)

• Source: BMC Infectious Diseases. 5/13/2024, Vol. 24 Issue 1, p1-8. 8p.

Record details

Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial.

• Authors : Huang T; Hunan Provincial Center for Disease Control and Prevention, Changsha, 410005, China.; Hu Q

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Vaccines, Subunit*

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Apr 19; Vol. 24 (1), pp. 413. Date of Electronic Publication: 2024 Apr 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details